DrugPatentWatch Database Preview» See Plans and Pricing
« Back to Dashboard
Promethazine hydrochlorideis the generic ingredient in thirteen branded drugs marketed by Wyeth Ayerst, Abbott, Akorn, Am Regent, Bedford Labs, Hospira, Marsam Pharms Llc, Mylan Institutional, Sandoz, Teva Pharms Usa, Watson Labs, West-ward Pharms Int, Wockhardt, Xgen Pharms, Altana, Mylan, Polymedica, Able, Cosette, Perrigo Israel, Taro, Watson Labs Inc, Usl Pharma, Alpharma Us Pharms, Actavis Mid Atlantic, Cenci, Amneal Pharms, Hi Tech Pharma, Kv Pharm, Nostrum Labs Inc, Pharm Assoc, Tris Pharma Inc, Vintage, Whiteworth Town Plsn, Ani Pharms, Wockhardt Bio Ag, Delcor Asset Corp, Amneal Pharms Ny, Impax Labs, Invatech, Ivax Sub Teva Pharms, Kvk Tech, Lannett, Prinston Inc, Pvt Form, Quagen, Strides Pharma, Sun Pharm Inds Inc, Sun Pharm Industries, Tablicaps, Teva, Zydus Pharms Usa, and Bristol Myers Squibb, and is included in eighty-seven NDAs. Additional information is available in the individual branded drug profile pages.
There are twelve drug master file entries for promethazine hydrochloride. Fifty suppliers are listed for this compound.
Summary for promethazine hydrochloride
Recent Clinical Trials for promethazine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
|University of Alabama at Birmingham||Phase 4|
|Hopital Psychiatrique De La Croix||Phase 4|
|University of Nottingham||Phase 4|
Pharmacology for promethazine hydrochloride
|Drug Class||Phenothiazine |
Medical Subject Heading (MeSH) Categories for promethazine hydrochloride
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Wyeth Ayerst||PHENERGAN||promethazine hydrochloride||INJECTABLE;INJECTION||008857-003||Approved Prior to Jan 1, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Prinston Inc||PROMETHAZINE HYDROCHLORIDE||promethazine hydrochloride||TABLET;ORAL||040622-002||Jul 18, 2006||AB||RX||No||No||Start Trial||Start Trial||Start Trial|
|Kvk Tech||PROMETHAZINE HYDROCHLORIDE||promethazine hydrochloride||TABLET;ORAL||040712-003||Jul 31, 2006||AB||RX||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.